Estrella Immunopharma enters consulting agreement with chairperson's company Cofame

Estrella Immunopharma, Inc.

Estrella Immunopharma entered a Consulting Agreement with Cofame Investment Management, owned by Chairperson Hong Zhang, for advisory services up to three days per week.
Cofame receives $55,000 upfront and an annual fee of $220,000; Hong Zhang granted option to purchase 1,000,000 shares under the 2023 Omnibus Incentive Plan.
Option vests 25% on August 1, 2025, with the remaining 75% vesting monthly over 36 months, contingent on continued service.
The Audit Committee reviewed and approved the agreement as a related-party transaction.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.